Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Increased collaboration between Mohs and plastic surgeons in the surgical management of skin cancer in Australia.

Venning VL, Moreno-Bonilla G, Stewart TJ, Lee S, Fernandez-Peñas P.

Australas J Dermatol. 2019 Jul 10. doi: 10.1111/ajd.13112. [Epub ahead of print] No abstract available.

PMID:
31292946
2.

Mohs Micrographic Surgery at the Skin and Cancer Foundation Australia, 20 Years Later (1997-2017).

Stewart TJ, Moreno Bonilla G, Venning VL, Lee S, Fernandez-Peñas P.

Dermatol Surg. 2019 Jul 1. doi: 10.1097/DSS.0000000000002010. [Epub ahead of print]

PMID:
31274529
3.

Data independent acquisition proteomic analysis can discriminate between actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma.

Azimi A, Yang P, Ali M, Howard V, Mann GJ, Kaufman KL, Fernandez-Penas P.

J Invest Dermatol. 2019 Jun 26. pii: S0022-202X(19)31794-4. doi: 10.1016/j.jid.2019.06.128. [Epub ahead of print]

PMID:
31254517
4.

Keratinocyte carcinoma as a chronic disease in Australia and Spain: The importance of avoidance of perceived visible scars.

Venning VL, Thomas CL, Consuegra Romero G, Castro Gutiérrez B, St George G, Fernandez-Peñas P.

Australas J Dermatol. 2019 Apr 10. doi: 10.1111/ajd.13050. [Epub ahead of print]

PMID:
30968391
5.

Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide.

Martin AJ, Dhillon HM, Vardy JL, Dalziell RA, Choy B, Fernández-Peñas P, Dixon A, Renton C, St George G, Chinniah N, Halliday GM, Damian DL, Chen AC.

Geriatrics (Basel). 2019 Mar 25;4(1). pii: E31. doi: 10.3390/geriatrics4010031.

6.

Management of cutaneous T-cell lymphomas: Established and emergent therapies.

Wain T, Venning VL, Consuegra G, Fernandez-Peñas P, Wells J.

Australas J Dermatol. 2019 Feb 26. doi: 10.1111/ajd.13011. [Epub ahead of print] Review.

PMID:
30809800
7.

Public body consciousness is associated with positive tanning attitudes and behaviours regardless of gender or age.

Venning VL, Abbott LM, Fernandez-Peñas P.

Australas J Dermatol. 2018 Dec 21. doi: 10.1111/ajd.12974. [Epub ahead of print] No abstract available.

PMID:
30575009
8.

Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma.

Hwang SJE, Park JJW, Wakade D, Chou S, Byth K, Fernandez-Penas P.

Melanoma Res. 2019 Apr;29(2):172-177. doi: 10.1097/CMR.0000000000000518.

PMID:
30273233
9.

Tape Stripped Stratum Corneum Samples Prove to be Suitable for Comprehensive Proteomic Investigation of Actinic Keratosis.

Azimi A, Ali M, Kaufman KL, Mann GJ, Fernandez-Penas P.

Proteomics Clin Appl. 2019 May;13(3):e1800084. doi: 10.1002/prca.201800084. Epub 2018 Oct 8.

PMID:
30247810
10.

Tanning, selfies and social media.

Abbott LM, Byth K, Fernandez-Penas P.

Australas J Dermatol. 2019 Feb;60(1):82-84. doi: 10.1111/ajd.12933. Epub 2018 Sep 23. No abstract available.

PMID:
30246240
11.

Use of immortal time within survival analysis.

Chan L, Byth K, Fernandez-Penas P.

J Am Acad Dermatol. 2019 Jan;80(1):e17. doi: 10.1016/j.jaad.2018.06.073. Epub 2018 Sep 15. No abstract available.

PMID:
30222986
12.

Management of the cutaneous adverse effects of antimelanoma therapy.

Liu RC, Consuegra G, Fernández-Peñas P.

Melanoma Manag. 2017 Dec;4(4):187-202. doi: 10.2217/mmt-2017-0015. Epub 2017 Nov 22. Review.

13.

Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature.

Zhao CY, Hwang SJE, Consuegra G, Chou S, Fernandez-Peñas P.

Melanoma Res. 2018 Dec;28(6):491-501. doi: 10.1097/CMR.0000000000000500.

PMID:
30169429
14.

Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma.

Zhao CY, Hwang SJE, Anforth R, Carlos G, Chou S, Carlino M, Fernández-Peñas P.

J Immunother. 2018 Sep;41(7):343-349. doi: 10.1097/CJI.0000000000000237.

PMID:
29939876
15.

Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study.

Leonardi C, Maari C, Philipp S, Goldblum O, Zhang L, Burkhardt N, Ball S, Mallbris L, Gonzalez P, Fernández-Peñas P, Puig L.

J Am Acad Dermatol. 2018 Nov;79(5):824-830.e2. doi: 10.1016/j.jaad.2018.05.032. Epub 2018 May 25.

PMID:
29803904
16.

Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas.

Zhao CY, Fernández-Peñas P.

Australas J Dermatol. 2018 Nov;59(4):e297-e298. doi: 10.1111/ajd.12829. Epub 2018 Apr 19. No abstract available.

PMID:
29672833
17.

Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.

Azimi A, Kaufman KL, Ali M, Arthur J, Kossard S, Fernandez-Penas P.

J Dermatol Sci. 2018 Jul;91(1):69-78. doi: 10.1016/j.jdermsci.2018.04.006. Epub 2018 Apr 10.

PMID:
29665991
18.

The efficacy and safety of methotrexate versus interferon in cutaneous T-cell lymphomas.

Wain T, Pavli A, Wells J, Fernandez-Peñas P.

J Dermatolog Treat. 2018 Nov;29(7):715-719. doi: 10.1080/09546634.2018.1441492. Epub 2018 Feb 25.

PMID:
29455635
19.

Cutaneous non-tuberculous mycobacteria in Western Sydney, Australia. Population study 1996-2013.

Moreno G, Minocha R, Choy B, Jelfs P, Watts M, Fernandez-Peñas P.

Australas J Dermatol. 2018 Nov;59(4):343-345. doi: 10.1111/ajd.12783. Epub 2018 Jan 26. No abstract available.

PMID:
29372556
20.

Naevus lightening in melanoma patients under BRAF/MEK inhibitor combination therapy versus checkpoint immunotherapy: A histological and immunohistochemistry analysis.

Zhao CY, Chou S, Liu RC, Fernandez-Peñas P.

Pigment Cell Melanoma Res. 2018 Mar;31(2):341-344. doi: 10.1111/pcmr.12669. Epub 2017 Nov 27. No abstract available.

PMID:
29131505

Supplemental Content

Loading ...
Support Center